Invention Grant
US08771645B2 Composition comprising a cell death marker and a wavelength-optimized label
有权
包含细胞死亡标记和波长优化标记的组合物
- Patent Title: Composition comprising a cell death marker and a wavelength-optimized label
- Patent Title (中): 包含细胞死亡标记和波长优化标记的组合物
-
Application No.: US12808012Application Date: 2008-12-15
-
Publication No.: US08771645B2Publication Date: 2014-07-08
- Inventor: Francesca Cordeiro , Stephen Moss , Frederick Fitzke
- Applicant: Francesca Cordeiro , Stephen Moss , Frederick Fitzke
- Applicant Address: GB London
- Assignee: UCL Business PLLC
- Current Assignee: UCL Business PLLC
- Current Assignee Address: GB London
- Agency: Stites & Harbison PLLC
- Agent Mandy Wilson Decker
- Priority: GB0724412.2 20071214
- International Application: PCT/GB2008/004156 WO 20081215
- International Announcement: WO2009/077750 WO 20090625
- Main IPC: A61B10/00
- IPC: A61B10/00 ; A61B5/00 ; A61B8/00 ; A61K51/08 ; A61K49/00
Abstract:
The invention relates to the use of a cell death marker labelled with a wavelength-optimised label for identifying cell death in the eye. Suitable cell death markers are the Annexins and fragments and derivatives thereof. The invention also relates to a pharmaceutical composition comprising a cell death marker labelled with a wavelength-optimised label and a method for monitoring cell death in the eye using a cell death marker labelled with a wavelength-optimised label.
Public/Granted literature
- US20100284922A1 MARKER Public/Granted day:2010-11-11
Information query
